Skip to main navigation Skip to search Skip to main content

A Reduced-Toxicity Regimen Is Associated with Durable Engraftment and Clinical Cure of Nonmalignant Genetic Diseases among Children Undergoing Blood and Marrow Transplantation with an HLA-Matched Related Donor

  • Kris Michael Mahadeo
  • , Kenneth I. Weinberg
  • , Hisham Abdel-Azim
  • , David B. Miklos
  • , Renna Killen
  • , Donald Kohn
  • , Gay M. Crooks
  • , Ami J. Shah
  • , Sandhya Kharbanda
  • , Rajni Agarwal
  • , Neena Kapoor

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)440-444
Number of pages5
JournalBiology of Blood and Marrow Transplantation
Volume21
Issue number3
DOIs
StatePublished - Mar 1 2015
Externally publishedYes

ASJC Scopus Subject Areas

  • Hematology
  • Transplantation

Keywords

  • Alemtuzumab
  • Nonmalignant diseases
  • Pediatrics
  • Reduced toxicity

Cite this